• Home
  • Cliantha Research Limited

Cliantha Research Limited

About Cliantha Research Limited

Cliantha Research, full-service Clinical Research Organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA-BE & Phase I), Late Phase (II-IV), Respiratory, Dermatology, Consumer Clinical Research,  IVRT/IVPT Biometrics, Medical Services, Environmental Exposure Chambers (EECs) and Veterinary Therapeutics. Some of the key regulators, such as the USFDA, EMA, AGES, ANSM, ANVISA, AMPS, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey MOH, Thailand MoPH, Malaysia NPRA have successfully inspected Cliantha. Has presence in USA, Canada, Europe & India.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Research Organisation (CRO)
Primary activities
Clinical Research
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from Cliantha Research Limited (4)

  • Biometrics

    Product Biometrics

    This division focuses on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. As experts in clinical data, Cliantha provides competent outsourcing solutions for Clinical Data Management, Biostatistics, Statistical Programming. We can offer study level suppor...
  • Lab Services

    Product Lab Services

    Cliantha Research provides scientific expertise with state-of-the-art technologies reinforced by commitment for quality delivery. Our comprehensive lab services include central lab testing, bioanalytical, Pharmacokinetics (PK) services, Immunogenicity (ADA), Bio marker, Vaccine Immunogenicity testing. 800...
  • Late Phase (Clinical Trials)

    Product Late Phase (Clinical Trials)

    2025+ Late Phase Studies, 25+ Therapeutic Categories, 100+ Indications, 5000+Sites, 51000+Patients, 75+ USFDA Site Audits , Therapeutic Categories Experience: Oncology, Biosimilars, Neuropsychiatry, Dermatology, Respiratory, Gastrointestinal, Ophthalmology, Neurology, Endocrinology, Immune Disorder, Inf...
  • Early Phase (BA/BE & Phase I)

    Product Early Phase (BA/BE & Phase I)

    Established in Year 2004, Cliantha has supported more than 500+ clients in conducting > 7500+, Phase-I, BA-BE studies, Patient Based PK studies, Clinical End-point studies (Phase-II to Phase-IV) & IVRT/IVPT studies. We provide following full scope services to Pharmaceutical / Biotech companies and s...

Cliantha Research Limited Resources (4)

  • BABE and Phase I Studies

    Brochure BABE and Phase I Studies

    7000+ Studies. Inspected by:USFDA, GCC, EMA, AGES, ANSM, ANVISA, AMPS, MCC South Africa, Health Canada, Malaysia NPRA, DCGI, CAP, NABL, Turkey MOH,Thailand MoPH
  • Late Phase Studies

    Brochure Late Phase Studies

    200+ Late Phase Studies, 25+ Therapeutic Categories, 100+ Indications, 2000+Sites, 31000+Patients, 60+ USFDA Site Audits
  • Lab Services

    Brochure Lab Services

    Our lab services include central lab testing, bioanalytical, Pharmacokinetics (PK) services, Immunogenicity (ADA), Bio marker, Vaccine Immunogenicity testing.
  • Biometrics

    Brochure Biometrics

    Cliantha provides competent outsourcing solutions for Clinical Data Management, Biostatistics, Statistical Programming.